BTG is a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible; supporting clinicians, healthcare systems and governments while offering hope to patients and their families. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain. Improving patients’ quality of life and offering hope is what motivates and inspires us. BTG was acquired by SERB Pharmaceuticals in 2020. SERB now operates in the US as BTG Pharmaceuticals.